EADC (EUROPEAN ALZHEIMER DISEASE CONSORTIUM) RECOMMENDATIONS FOR FUTURE ALZHEIMER DISEASE RESEARCH IN EUROPE

被引：0
|
作者：
Winblad, B. [1 ]
Frisoni, G. B.
Johannsen, Frolich P.
Johansson, G.
Kehoe, P.
Lovestone, S.
Olde-Rikkert, M.
Reynish, E.
Visser, P. J.
Vellas, B. [2 ]
机构：
[1] Karolinska Inst, Alzheimers Dis Res Ctr, Stockholm, Sweden
[2] CHU Toulouse, Toulouse, France
来源：
JOURNAL OF NUTRITION HEALTH & AGING | 2008年 / 12卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：683 / 684
页数：2
相关论文
共 50 条
  • [21] Serum BDNF and Alzheimer's disease severity: An investigation by the Texas Alzheimer's Disease Research Consortium (TARC)
    Hobson, V. L.
    O'Bryant, S.
    Hall, J.
    Cullum, M.
    Lacritz, L.
    Massman, P.
    Waring, S.
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2008, 23 (06) : 674 - 674
  • [22] Future horizons in Alzheimer's disease research
    Wisniewski, Thomas
    Drummond, Eleanor
    MOLECULAR BIOLOGY OF NEURODEGENERATIVE DISEASES: VISIONS FOR THE FUTURE, PT A, 2019, 168 : 223 - 241
  • [23] The Clinical Use of Alzheimer's Disease Biomarkers in Patients with Mild Cognitive Impairment: A European Alzheimer's Disease Consortium Survey
    Caprioglio, Camilla
    Garibotto, Valentina
    Jessen, Frank
    Froelich, Lutz
    Allali, Gilles
    Assal, Frederic
    Frisoni, Giovanni B.
    Altomare, Daniele
    JOURNAL OF ALZHEIMERS DISEASE, 2022, 89 (02) : 535 - 551
  • [24] European Union research policy and funding for Alzheimer disease
    Cupers, Philippe
    Sautter, Jurgen
    Vanvossel, Alain
    NATURE MEDICINE, 2006, 12 (07) : 774 - 775
  • [25] European Union research policy and funding for Alzheimer disease
    Philippe Cupers
    Jürgen Sautter
    Alain Vanvossel
    Nature Medicine, 2006, 12 : 774 - 775
  • [26] The use of biomarkers for the etiologic diagnosis of mild cognitive impairment in Europe: a survey of the European Alzheimer's disease consortium
    Bocchetta, M.
    Galluzzi, S.
    Kehoe, P.
    Frisoni, G. B.
    JOURNAL OF NEUROLOGY, 2014, 261 : S79 - S80
  • [27] The use of biomarkers for the etiologic diagnosis of mild cognitive impairment in Europe: a survey of the European Alzheimer's disease consortium
    Bocchetta, M.
    Galluzzi, S.
    Kehoe, P.
    Frisoni, G. B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 110 - 110
  • [28] Staging of neurofibrillary pathology in Alzheimer's disease:: A study of the BrainNet Europe consortium
    Alafuzoff, Irina
    Arzberger, Thomas
    Al-Sarraj, Safa
    Bodi, Istvan
    Bogdanovic, Nenad
    Braak, Heiko
    Bugiani, Orso
    Del-Tredici, Kelly
    Ferrer, Isidro
    Gelpi, Ellen
    Giaccone, Giorgio
    Graeber, Manuel B.
    Ince, Paul
    Kamphorst, Wouter
    King, Andrew
    Korkolopoulou, Penelope
    Kovacs, Gabor G.
    Larionov, Sergey
    Meyronet, David
    Monoranu, Camelia
    Parchi, Piero
    Patsouris, Efstratios
    Roggendorf, Wolfgang
    Seilhean, Danielle
    Tagliavini, Fabrizio
    Stadelmann, Christine
    Streichenberger, Nathalie
    Thal, Dietmar R.
    Wharton, Stephen B.
    Kretzschmar, Hans
    BRAIN PATHOLOGY, 2008, 18 (04) : 484 - 496
  • [29] Alzheimer's disease research: the future of BACE inhibitors
    Burki, Talha
    LANCET, 2018, 391 (10139): : 2486 - 2486
  • [30] Clustering of behavioural and psychological symptoms in dementia (BPSD) - Within and beyond the 12 items of Neuropsychiatric Inventory: a European Alzheimer's disease Consortium (EADC) study
    Petrovic, M
    Hurt, C
    Collins, D
    INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 : 176 - 177
12345